Quantcast

Latest Endocyte Inc. Stories

2014-07-18 20:21:38

SAN DIEGO and WEST LAFAYETTE, Ind., July 18, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP, which filed the initial class action complaint against Endocyte, Inc. (NASDAQ: ECYT) and certain of its officers and directors, reminds investors that they have until August 25, 2014 to file a motion seeking to be appointed lead plaintiff. The class action was filed on behalf of all persons who purchased or otherwise acquired Endocyte securities between March 21, 2014 and...

2014-06-25 20:22:13

NEW YORK, June 25, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Endocyte, Inc. ("Endocyte" or the "Company") (NASDAQ: ECYT) concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws. http://photos.prnewswire.com/prnvar/20120215/MM54604LOGO For years Endocyte has been conducting studies of a therapy for ovarian cancer called "RECIST." In March...

2014-06-25 12:25:16

NEW YORK, June 25, 2014 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Indiana on behalf of a class (the "Class") comprising all purchasers of the common stock of Endocyte, Inc. ("Endocyte" or the "Company") (NASDAQ: ECYT) between March 21, 2014 and May 2, 2014, inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must...

2014-06-24 16:24:38

SAN DIEGO and WEST LAFAYETTE, Ind., June 24, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that it has filed a federal securities class action lawsuit on June 24, 2014, in the U.S. District Court for the Southern District of Indiana (the "Court"), on behalf of all persons who purchased or otherwise acquired Endocyte, Inc. ("Endocyte" or the "Company") (NASDAQ:ECYT) securities between March 21, 2014 and May 2, 2014, inclusive (the "Class Period"),...

2012-08-04 01:54:56

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease —— although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. Over 600,000 people in the U.S., and 12 million worldwide, are affected by the inherited kidney disease known as autosomal-dominant polycystic kidney disease (ADPKD or...

a2d028bdcb5c719cc04a98a16dacc6551
2009-07-06 14:45:00

A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease.A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.A radioimaging application used for body scans is expected to enter clinical trials this fall, and an optical imaging application used to measure...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related